Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P20
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-58.33%
2023-1.89%
202259.70%
2021-911.54%
2020-30.00%
20190.00%